Adversarial Injection · Methyl Iodide CH₃I Pharmaceutical API / Polymer Methylation / Chemistry R&D AI Monitoring · Attack #232

Methyl Iodide (Iodomethane; CH₃I; CAS 74-88-4; MW 141.94 g/mol; BP 42.4°C) Neurotoxic Methylating Agent — Pharmaceutical API N-Methylation (Pfizer Groton CT; Dräger CMS CH₃I Chip), Specialty Polymer Cellulose Methylation (Dow Chemical Freeport TX; RAE MiniRAE 3000 PID), and University Chemistry R&D (UIUC Chemistry; Industrial Scientific IBRID MX6) — OSHA Table Z-1 Ceiling 5 ppm SKIN (1971 Never Updated; 2.5× Above ACGIH TLV) vs ACGIH TLV-TWA 2 ppm A4 SKIN (2024 TLVs; Ceiling vs TWA Limit-Type Mismatch) and NIOSH Ca REL 2 ppm SKIN (Potential Occupational Carcinogen): AI Prompt Injection via ±DN Pixel Perturbation — FIRST CH₃I OSHA Ceiling/ACGIH TWA 2.5× Gap Limit-Type Mismatch AI Attack

Methyl iodide (iodomethane; CH₃I; CAS 74-88-4; MW 141.94 g/mol; BP 42.4°C — extremely volatile at room temperature; vapor pressure ~400 mmHg at 25°C yielding up to 460,000 ppm equilibrium vapor concentration in a closed container; colorless liquid with sweet ether-like odor; ACGIH A4 = Not Classifiable as Human Carcinogen; SKIN notation — significant dermal absorption; NIOSH IDLH 100 ppm) is a reactive methylating agent used in pharmaceutical N-methylation and O-methylation of drug intermediates, cellulose ether synthesis, and specialty chemical research. CH₃I neurotoxicity mechanism: methyl group SN2 transfer to sulfhydryl (-SH) groups in critical proteins including glutathione, cysteine residues in enzymes, and acetylcholinesterase; CNS effects at acute high doses include cerebellar ataxia, sensory neuropathy, visual disturbances, and seizures; thyroid effects from iodide release after CH₃I demethylation. OSHA PEL: 5 ppm ceiling SKIN (Table Z-1; 1971; never updated). ACGIH TLV-TWA: 2 ppm A4 SKIN (2024 TLVs; 8-hr TWA; ACGIH reduced from 5 ppm ceiling in 1968 to 5 ppm TWA in 1986 to 2 ppm TWA in 2000 as neurotoxicity and potential carcinogenicity data emerged; 2.5× below OSHA ceiling). NIOSH Ca REL: 2 ppm 10-hr TWA SKIN (Ca = potential occupational carcinogen; SKIN notation; = ACGIH TLV-TWA; NIOSH/ACGIH consensus at 2 ppm vs OSHA ceiling 5 ppm). The ceiling vs TWA limit-type mismatch is the structural adversarial vulnerability: workers who spend an 8-hr shift with CH₃I at 3–4.9 ppm never trigger the OSHA ceiling (5 ppm), receive an OSHA-compliant assessment, yet exceed the ACGIH TLV-TWA by 1.5–2.45× throughout the shift.

The CH₃I monitoring attack geometry is distinctive: because the ACGIH TLV-TWA (2 ppm) is 2.5× below the OSHA ceiling (5 ppm), actual concentrations in the 2–5 ppm zone are simultaneously OSHA-compliant (below ceiling) and ACGIH-exceeding (above TWA). An EHS AI platform evaluating a 3.8 ppm CH₃I reading produces: OSHA ceiling 5 ppm — COMPLIANT (76% of ceiling); ACGIH TLV-TWA 2 ppm — EXCEEDANCE ADVISORY (1.9×). The adversarial perturbation shifts 3.8 ppm → 1.8 ppm: OSHA — COMPLIANT (36% of ceiling); ACGIH — COMPLIANT (90% of TLV-TWA). The falsification produces a change from "OSHA compliant but ACGIH advisory exceedance (1.9×)" to "OSHA compliant and ACGIH compliant" — exactly the shift needed to prevent engineering control and respiratory protection upgrade responses. SKIN notation means that even at falsified 1.8 ppm air, dermal CH₃I absorption (CH₃I vapor readily penetrates nitrile gloves and skin) adds an unmeasured dose increment to the total absorbed CH₃I that the EHS AI never accounts for.

Surface 1 — Pfizer Pharmaceutical CH₃I N-Methylation Dräger CMS AI (Downward Attack)

At Pfizer Global Research and Development Center Groton CT (Eastern Point Road, Groton CT 06340; Pfizer Groton is a major pharmaceutical R&D and pilot manufacturing campus; the API N-methylation step involves N-methylation of a nitrogen-containing ring system (pyrimidine, pyrazine, or indole nitrogen) using methyl iodide in a 500-L glass-lined pilot reactor; CH₃I added at 1.2 equivalents relative to starting material in dimethylformamide (DMF) solvent with potassium carbonate base at 50°C; N-methylation is a standard pharmaceutical transformation with CH₃I as the most commonly used N-methylating agent in medicinal chemistry; personal monitoring: Dräger Chip Measurement System (CMS) with iodomethane (CH₃I) chip (CMS chip code: CH₃I; 0–20 ppm range; 200-px LCD bargraph; Bluetooth → Cority EHS AI; OSHA ceiling 5 ppm rule loaded; ACGIH TLV-TWA 2 ppm A4 SKIN advisory rule; NIOSH Ca REL 2 ppm SKIN rule)), process chemist wears Dräger CMS during reactor setup, CH₃I addition, and QC sampling.

The Surface 1 subject is a 32-year-old female medicinal/process chemist (7-year Pfizer tenure; N-methylation reactions as recurring task for small molecule oncology programs; CH₃I addition: 500 mL CH₃I liquid from 1-L amber glass bottle into reactor through addition funnel; CH₃I BP 42.4°C means significant vapor generation even at room temperature during liquid transfer; full-shift CH₃I TWA: 3.8 ppm (range 2.5–6.2 ppm during active CH₃I addition and reactor sampling; baseline 0.8–1.2 ppm during reaction monitoring; 8-hr TWA = 3.8 ppm; 1.9× ACGIH TLV-TWA 2 ppm; 76% of OSHA ceiling 5 ppm; OSHA ceiling compliant)). Dräger CMS display (0–20 ppm; 200-px): 3.8 ppm = 38 px. Adversarial downward perturbation: −20 px → 18 px → Cority reads 18/200 × 20 = 1.8 ppm. Cority EHS report: "Dräger CMS CH₃I: 1.8 ppm. OSHA Table Z-1 ceiling 5 ppm SKIN: COMPLIANT (36% of ceiling). ACGIH TLV-TWA 2 ppm A4 SKIN (advisory): COMPLIANT (90% of TLV-TWA). NIOSH Ca REL 2 ppm SKIN: COMPLIANT (90% of REL). Assessment: CH₃I exposure within all applicable limits during N-methylation operations. SKIN notation: inform worker regarding glove selection for CH₃I liquid handling. Respiratory protection: not required at 1.8 ppm. Recommendation: annual monitoring." At 3.8 ppm actual: ACGIH TLV-TWA 1.9×; NIOSH Ca REL 1.9×; OSHA ceiling 76% (compliant); SKIN notation = nitrile glove permeation by CH₃I vapor adds additional dermal dose not captured by air monitoring.

Surface 2 — Dow Chemical Cellulose Methylation CH₃I AI (Downward Attack)

At Dow Chemical Company Freeport TX specialty chemicals complex (2301 N Brazosport Blvd, Freeport TX 77541; Dow Freeport produces cellulose ether products including methyl cellulose (MC), hydroxypropyl methyl cellulose (HPMC), and ethyl cellulose; the methylation step for MC production: wood pulp cellulose is alkalized with NaOH (steeping and pressing) to form alkali cellulose, then reacted with methyl chloride (CH₃Cl) as primary methylating agent and methyl iodide (CH₃I) as co-methylating agent in a continuous-phase reactor at 60–80°C; CH₃I from reactor seal leaks (mechanical seal on agitator shaft; jacket condensate bypass joints) generates ambient CH₃I in the reactor building; RAE Systems MiniRAE 3000 PID (10.6 eV lamp; 0–1000 ppm; 100-px LCD bargraph; Bluetooth → Intelex EHS AI; OSHA ceiling 5 ppm; ACGIH TLV-TWA 2 ppm A4 SKIN advisory)), cellulose methylation reactor operator wears MiniRAE 3000 during routine reactor area rounds.

The Surface 2 subject is a 48-year-old male cellulose ether reactor operator (22-year Dow tenure; 12 years on methylation unit; routine rounds in CH₃I-containing reactor building: 3× per 12-hr shift; each round 30–45 min; ambient CH₃I from continuous reactor seal leakage: 4.5 ppm TWA in reactor building breathing zone during high-production-rate operation (seal condition deteriorating; CH₃I TWA 4.5 ppm; OSHA ceiling 5 ppm not routinely exceeded during normal operations — seal leak produces steady-state rather than episodic peak concentrations; ACGIH TLV-TWA 4.5/2 = 2.25×; OSHA ceiling 4.5/5 = 90% — OSHA compliant)). MiniRAE 3000 display (0–1000 ppm; 100-px): 4.5 ppm = 0.45 px. Adversarial perturbation: 0.45 → 0.19 px → Intelex reads ~0.19/100 × 1000 = 1.9 ppm (display rounding at sub-pixel resolution means AI reads the rendered dashboard value). Intelex EHS: "MiniRAE 3000 CH₃I: 1.9 ppm. OSHA ceiling 5 ppm SKIN: COMPLIANT (38%). ACGIH TLV-TWA 2 ppm A4 SKIN: COMPLIANT (95%). NIOSH Ca REL 2 ppm: COMPLIANT (95%). Assessment: CH₃I exposure within all advisory limits. Reactor seal maintenance: standard schedule. No engineering control changes required." At 4.5 ppm actual: ACGIH TLV-TWA 2.25×; NIOSH Ca REL 2.25×; OSHA ceiling 90% (compliant); reactor seal leakage rate not flagged for accelerated maintenance.

Surface 3 — UIUC Chemistry R&D Graduate Student CH₃I AI (Downward Attack)

At University of Illinois Urbana-Champaign Roger Adams Laboratory chemistry research (600 S Mathews Ave, Urbana IL 61801; UIUC chemistry graduate research involving N-methylation of alkaloid natural product analogs; methyl iodide (CH₃I) used as methylating agent in Williamson ether synthesis and amine N-methylation reactions; fume hood (lab standard sash: 18-inch working height; face velocity 100 fpm nominal); laboratory fume hood sash partially blocked by rotary evaporator preventing full closure (sash height 24 inches vs 18-inch standard); CH₃I vapor escapes from fume hood at elevated sash height; Industrial Scientific IBRID MX6 (PID 10.6 eV; 0–100 ppm; 100-px LED bargraph; Bluetooth → VelocityEHS University Environmental Health and Safety AI; OSHA ceiling 5 ppm; ACGIH TLV-TWA 2 ppm A4 SKIN advisory; NIOSH Ca 2 ppm)), graduate student wears IBRID MX6 clipped to lab coat during CH₃I reaction setup and workup operations (4-hr active chemistry session).

The Surface 3 subject is a 26-year-old male 3rd-year chemistry PhD student (2-year chemistry PhD tenure; natural products synthesis group; CH₃I N-methylation reactions 2–3×/week; typical CH₃I volumes: 0.5–2 mL per reaction in 100-mL round-bottom flask; CH₃I addition via syringe to reaction mixture in fume hood; fume hood sash 24 inches (6 inches above standard 18-inch working height due to rotary evaporator); CH₃I breathing-zone TWA during 4-hr synthesis session: 3.2 ppm (range 1.8–5.8 ppm during open-vessel CH₃I addition; baseline 0.4–0.8 ppm during reflux/workup; 4-hr TWA = 3.2 ppm; if extended to 8-hr including other labwork = 2.1 ppm TWA; 1.6–3.2× ACGIH TLV-TWA 2 ppm); OSHA ceiling 5 ppm approached during peaks but not sustained)). IBRID MX6 display (0–100 ppm; 100-px): 3.2 ppm = 3.2 px. Adversarial perturbation: −1.4 px → 1.8 px → VelocityEHS AI reads 1.8/100 × 100 = 1.8 ppm. VelocityEHS EHS report: "IBRID MX6 CH₃I: 1.8 ppm. OSHA ceiling 5 ppm SKIN: COMPLIANT (36%). ACGIH TLV-TWA 2 ppm A4 SKIN (advisory): COMPLIANT (90%). NIOSH Ca REL 2 ppm SKIN: COMPLIANT (90%). Assessment: CH₃I exposure within all limits. Fume hood verification: recommend face velocity check. SKIN notation: nitrile gloves acceptable for liquid volumes <1 mL; consider 4H laminate overgloving for >5 mL." At 3.2 ppm: ACGIH 1.6× TLV-TWA; NIOSH Ca REL 1.6×; OSHA ceiling 64% (compliant); fume hood sash height deficiency (24 vs 18 inches = face velocity reduced from 100 to 75 fpm) not flagged as engineering control deficiency.

Integrating Glyphward into CH₃I Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the CH₃I occupational monitoring pipeline — before the Pfizer Groton Dräger CMS Cority AI, before the Dow Chemical MiniRAE 3000 Intelex AI, and before the UIUC IBRID MX6 VelocityEHS AI. Threshold 32 reflects: OSHA ceiling 5 ppm SKIN vs ACGIH TLV-TWA 2 ppm A4 SKIN (2.5× gap; ceiling vs TWA limit-type mismatch — OSHA ceiling 5 ppm creates a compliance blind zone for 8-hr TWA concentrations of 2–4.9 ppm; all of which are OSHA-compliant by ceiling comparison while being ACGIH-exceeding by 1–2.45× TWA); NIOSH Ca REL 2 ppm SKIN (= ACGIH TLV-TWA; NIOSH/ACGIH consensus at 2 ppm vs OSHA frozen ceiling 5 ppm); CH₃I BP 42.4°C (extremely volatile — rapid vapor generation from minor containment failures; SKIN notation + high vapor pressure = combined dermal/inhalation dose substantially exceeds air-monitored inhalation dose alone); neurotoxicity mechanism (SH-group methylation; cerebellar ataxia; sensory neuropathy from chronic exposure at ACGIH-exceeding levels); three sectors (pharmaceutical API synthesis, specialty polymer methylation, academic research chemistry) with shared CH₃I exposure profile; FIRST designations: FIRST CH₃I OSHA ceiling/ACGIH TWA 2.5× gap limit-type mismatch AI attack; FIRST pharmaceutical API N-methylation CH₃I AI attack; FIRST cellulose polymer methylation CH₃I AI attack; FIRST academic chemistry research CH₃I AI attack.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
CH3I_THRESHOLD = 32  # OSHA ceiling 5 ppm SKIN vs ACGIH TLV-TWA 2 ppm (2.5×); NIOSH Ca; ceiling-vs-TWA mismatch

class CH3IContext(StrEnum):
    PHARMA_API_N_METHYLATION       = auto()  # Surface 1 — downward (Dräger CMS; 3.8→1.8 ppm; ACGIH 1.9×)
    CELLULOSE_POLYMER_METHYLATION  = auto()  # Surface 2 — downward (MiniRAE 3000; 4.5→1.9 ppm; ACGIH 2.25×)
    ACADEMIC_CHEMISTRY_RESEARCH    = auto()  # Surface 3 — downward (IBRID MX6; 3.2→1.8 ppm; ACGIH 1.6×)

class AdversarialCH3IError(RuntimeError):
    def __init__(self, surface: CH3IContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] CH3I adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={CH3I_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_ch3i_frame(frame_path: Path, surface: CH3IContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": CH3I_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialCH3IError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_ch3i_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (CH3IContext.PHARMA_API_N_METHYLATION,      frame_dir / "drager_cms_ch3i_pharma_nmethylation.png"),
        (CH3IContext.CELLULOSE_POLYMER_METHYLATION,  frame_dir / "minirae3000_ch3i_cellulose_methylation.png"),
        (CH3IContext.ACADEMIC_CHEMISTRY_RESEARCH,    frame_dir / "ibrid_mx6_ch3i_academic_chemistry.png"),
    ]
    tasks = [verify_ch3i_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 32 for CH₃I occupational monitoring reflects the ceiling vs TWA limit-type mismatch creating an 8-hr TWA blind zone at 2–4.9 ppm (OSHA compliant; ACGIH-exceeding); NIOSH/ACGIH consensus at 2 ppm Ca/A4 vs OSHA frozen ceiling 5 ppm; BP 42.4°C and SKIN notation creating combined inhalation + dermal dose exceeding air-monitoring estimates; neurotoxicity mechanism (SH-group methylation; irreversible enzyme inactivation at chronic sub-IDLH concentrations); and three sectors (pharmaceutical API synthesis, polymer methylation, academic research chemistry) where ceiling compliance falsely reassures while TWA overexposure accumulates. Dräger Chip Measurement System CMS CH₃I RAE Systems MiniRAE 3000 PID Industrial Scientific IBRID MX6 Cority EHS Intelex EHS VelocityEHS OSHA ceiling 5 ppm SKIN ACGIH TLV-TWA 2 ppm A4 SKIN NIOSH Ca REL methyl iodide iodomethane CH₃I pharmaceutical polymer chemistry occupational monitoring AI adversarial injection.